[1] 袁丹, 容如滨, 喻宗沅, 等. 抗肿瘤药物10-羟基喜树碱的研究与应用进展[J]. 化学与生物工程, 2008, 24(12): 9-11.
[2] 王磊, 李玉艳, 尤启冬. DNA 拓扑异构酶Ⅰ抑制药: 抗肿瘤药喜树碱类衍生物的研究进展[J]. 中国药师, 2003, 6(7): 402-405.
[3] 潘显道, 王存英. 天然抗肿瘤药喜树碱衍生物的研究进展[J]. 药学学报, 2008(9): 715-720.
[4] Zolotarskaya O Y, Wagner A F, Beckta J M, et al. Synthesis of water soluble camptothecinpolyoxetane conjugates via click chemistry[J]. Molecular Pharmaceutics, 2012, 9(11): 3403-3408.
[5] Ulukan H, Swaan P W. Camptothecins: a review of their chemotherapeutic potential[J]. Drugs, 2002, 62(14): 2039-2057.
[6] Pommier Y. DNA topoisomerase I inhibitors: chemistry, biology and interfacial inhibition[J]. Chemical Reviews, 2009, 109(7): 2894-2905.
[7] Cao Z, Harris N, Kozielski A, et al. Alkyl esters of camptothecin and 9nitrocamptothecin: synthesis, in vitro pharmacokinetics, toxicity, and antitumor activity[J]. J Med Chem, 1998, 41(1): 31-37.
[8] Safavy A. Recent developments in taxane drug delivery[J]. Current Drug Delivery, 2008, 5(1): 42-54.
[9] Lu H, Lin H, Jiang Y, et al. Synthesis and antitumor activity of 20Olinked succinate-based camptothecin ester derivatives[J]. Letters in Drug Design; Discovery, 2006, 3(2): 83-86.
[10] 袁飞, 何琳, 丁沐淦, 等. 静态法与动态法测定药物水中溶解度的探讨[J]. 广东药学院学报, 2010, 26(5): 462-464.
[11] Herrmann M, Lorenz H, Voll R, et al. A rapid and simple method for the isolation of apoptotic DNA fragments[J]. Nucleic Acids Research, 1994, 22(24): 5506-5511.
[12] Janss A J, Cnaan A, Zhao H, et al. Synergistic cytotoxicity of topoisomerase I inhibitors with alkylating agents and etoposide in human brain tumor cell lines[J]. Anticancer Drugs, 1998, 9(7): 641-652.
[13] Lavergne O, Lesueur Ginot L, Rodas F P, et al. Homocamptothecins: synthesis and antitumor activity of novel E-ring modified camptothecin analogues[J]. Journal of Medicinal Chemistry, 1998, 41(27): 5410-5419.
[14] Song L, Bevins R, Anderson B D. Kinetics and mechanisms of activation of alphaamino acid ester prodrugs of camptothecins[J]. J Med Chem, 2006, 49(14): 4344-4355.
[15] Greenwald R B, Pendri A, Conover C D, et al. Camptothecin-20-PEG ester transport forms: the effect of spacer groups on antitumor activity[J]. Bioorganic & Medicinal Chemistry, 1998, 6(5): 551-562.